GSK Partners Adimab and Takes MAb Platform In-House
GlaxoSmithKline says MAbs (monoclonal antibodies) will play an important part in its future pipeline as it licenses and internalizes a discovery tech platform from Adimab.
Archives for August 1, 2013
Chinese Hamster Genome a Boon for BioPharmas say Researchers
Making better CHO cell lines for biomanufacturing may soon be a more precise task according to the team behind the draft Chinese hamster genome published last week.
Heat Stabilization Tech Aims to Overcome Limitations in Mass Spec Imaging
New heat stabilization technology can preserve the quality of tissue samples used in mass spectrometry imaging to improve the accuracy of downstream analytical results.
Recent Endorsements Encouraging for Hospira's Biosimilar Programme
As the market becomes more comfortable with biosimilars, recent European approval and development deals are driving Hospira forward, the firm says.
Piramal Invests $2.5m to Expand ADC Capacity in Scotland
Piramal is upgrading its ADC (antibody drug conjugate) manufacturing capacity in response to demand from clients in late phase trials looking to ramp up production.